AD/PD™ 2024 Faculty - Mark Roithmayr
Mark Roithmayr, CEO of the ADDF, invites you to #ADPD2024 and shares the sessions he is looking forward to at the Conference.
Join us at AD/PD™ 2024, where scientific professionals from all over the world come together and discuss the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development, and clinical trials in Alzheimer’s, Parkinson’s, and other related neurological disorders. https://adpd.kenes.com/